Influence of SSRI on blood coagulation;Der Einfluss von selektiven Serotonin-Wiederaufnahmeinhibitoren auf die Blutgerinnung

Fortschritte der Neurologie Psychiatrie

Volumn 66, Issue 1, 1998, Pages 32-35

  Bottlender, R ^a,b   Dobmeier, P ^a   Moller H J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CYTOCHROME P450; SEROTONIN UPTAKE INHIBITOR;

ANTICOAGULATION; ARTICLE; BLEEDING; DRUG EFFECT; DRUG MECHANISM; FIBRINOLYSIS; HUMAN; PSYCHOPHARMACOLOGY;

EID: 0031906091     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-995236     Document Type: Article

References (30)

1. Alderman, C. P., C. K. Moritz, D. I. Ben-Tovim: Abnormal platelet aggregation associated with fluoxetine therapy. Ann-Pharmacother. Dec. 26 (12) (1992) 1517-1519
2. Alderman, C. P., P. Seshadri, D. I. Ben-Tovim: Effects of serotonin reuptake inhibitors on hemostasis. Ann-Pharmacother. 30 (11) (1996) 1232-1234
3. Aranth, J., C. Lindberg: Bleeding, a side effect of fluoxetine. Am. J. Psychiatry Mar. 149 (3) (1992) 412
4. Askinazi, C.: SSRI treatment of depression with comorbid cardiac disease. Am. J. Psychiatry Jan. 153 (1) (1996) 135-136
5. Bannister, S. J., V. P. Houser, J. D. Hulse, J. C. Kisicki, J. G. Rasmussen: Evaluation of the potential for interactions of paroxetine with diazepam, cimetidine, warfarin, and digoxin. Acta Psychiatr. Scand. Suppl. 350 (1989) 102-106
6. Berk, M., B. F. Jacobson, E. Hurly: Fluoxetine and hemostatic function: a pilot study. J. Clin. Psychiatry Jan. 56 (1) (1995) 14 -16
7. Brosen, K.: Drug metabolizing enzymes and therapeutic drug monitoring in psychiatry. Ther. Drug Monit. Aug. 18 (4) (1996) 393 -396
8. Calhoun, J. W., D. D. Calhoun: Prolonged bleeding time in a patient treated with sertraline. Am. J. Psychiatry Mar. 153 (3) (1996) 443
9. Claire, R. J., M. E. Servis, D. L. Cram Jr.: Potential interaction between warfarin sodium and fluoxetine. Am. J. Psychiatry Nov. 148 (11) (1991) 1604
10. De Clerck, F.: The role of serotonin in thrombogenesis. Clin. Physiol. Biochem. 8, Suppl. 3 (1990) 40-49
11. Evans, T. G., S. S. Buys, G. M. Rodgers: Letter in N. Engl. J. Med. 324 (1991) 1671
12. George, J. N., S. J. Shattil: The clinical importance of acquired abnormalities of platelet function. N. Engl. J. Med. Jan. 3. 324 (1) (1991) 27-39
13. Gunzberger, D. W., D. Martinez: Adverse vascular effects associated with fluoxetine. Am. J. Psychiatry Dec. 149 (12) (1992) 1751
14. Hampel, H., C. Berger, H. J. Kuss, F. Müller-Spann: Unstable anti-coagulation in the course of amitriptyline treatment Pharmacopsychiatry Jan. 29 (1) (1996) 33-37
15. Hoeksema, T., J. G. Goekoop, G. M. van Kempen: Effects of fluvoxamine on whole blood serotonin and platelet number. J. Clin. Psychopharmacol. Feb. 13 (1) (1993) 75-76
16. Humphries, J. E., M. S. Wheby, S. R. VandenBerg: Fluoxetine and the bleeding time. Arch Pathol. Lab. Med. Jul. 114 (7) (1990) 727-728
17. Kremer, H. P., J. G. Goekoop, G. M. van Kempen: Clinical use of the determination of serotonin in whole blood. J. Clin. Psychopharmacol. Apr. 10 (2) (1990) 83-87
18. Lemberger, L., R. F. Bergstrom, R. L. Wolen, N. A. Farid, G. G. Enas, G. R. Aronoff: Fluoxetine: clinical pharmacology and physiologic disposition. J. Clin. Psychiatry Mar. 46 (3 Pt 2) (1985) 14-19
19. Leung, M., R. Shore: Fluovoxamine-associated bleeding. Can. J. Psychiatry 41 (9) (1996) 604-605
20. Ortiz, J., F. Artigas: Effects of monoamine uptake inhibitors on extracellular and platelet 5 hydroxytryptamine in rat blood: different effects of clomipramine and fluoxetine. Br. J. Pharmacol. Apr. 105 (4) (1992) 941-946
21. Ottervanger, J. P., P. M. van den Bemt, G. H. de Koning, B. H. Strikker: Risk of hemorrhage with the use of fluoxetine (Prozac) or fluvoxamine (Fevarin). Ned. Tijdschr. Geneeskd. Jan. 30, 137 (5) (1993) 259-261
22. Ottervanger, J. P., B. H. Stricker, J. Huls, J. N. Weeda: Bleeding attributed to the intake of paroxetine. Am. J. Psychiatry May 151 (5) (1994) 781-782
23. Pai, V. B., M. W. Kelly: Bruising associated with the use of fluoxetine. Ann. Pharmacother. Jul., Aug. 30 (7, 8) (1996) 786-788
24. Pietraszek, M. H., Y. Takada, A. Takada: Effect of mental stress on platelet aggregation: possible link to catecholamine levels. Haemostasis 21 (6) (1991) 346-352
25. Preis, R.: Arzneimittelinteraktionen mit oralen Antikoagulantien. Dtsch. Gesundheitsw. 34 (1979) 673-689
26. Stanford, M. S., J. H. Patton: In utero exposure to fluoxetine HCl increases hematoma frequency at birth. Pharmacol. Biochem. Behav. Aug. 45 (4) (1993) 959-962
27. Urano, T., J. Malyszko, Y. Takada, A. Takada: Close relationships between serotonergic and fibrinolytic systems revealed by a monoamine oxidase inhibitor treatment in rats. Haemostasis Nov., Dec. 25 (6) (1995) 277-282
28. Warnock, J. K., A. H. Clayton, H. A. Shaw, T. O'Donnell: Onset of menses in two adult patients with Prader Willi syndrome treated with fluoxetine. Psychopharmacol. Bull. 31 (2) (1995) 239 -242
29. Woolfrey, S., N. S. Gammack, M. S. Dewar, P. J. Brown: Fluoxetinewarfarin interaction. BMJ Jul. 24, 307 (6898) (1993) 241
30. Yaryura-Tobias, J. A., H. Kirschen, P. Ninan, H. J. Mosberg: Fluoxetine and bleeding in obsessive compulsive disorder. Am. J. Psychiatry Jul. 148 (7) (1991) 949